Impella ECP for High Risk Percutaneous Coronary Interventions

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
High Risk Percutaneous Coronary InterventionsImpella ECP - Device
Eligibility
18 - 90
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing how safe and effective the Impella ECP device is for people undergoing a high-risk heart procedure.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
AcumenTM HPI Software Feature
1
Squatting Assist Device
1
Smart Physiotherapy Activity Recognition System (SPARS)

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: through end of study, 30 days

Day 1
Feasibility: successful hemodynamic support
Procedural Success
Safety: Major Device-Related Adverse Events
Technical Success
Day 30
Rate of composite Major Device-Related Adverse Events
Rate of each individual Major Device-Related Adverse Event

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
AcumenTM HPI Software Feature
2
Squatting Assist Device
1
Smart Physiotherapy Activity Recognition System (SPARS)

Trial Design

1 Treatment Group

Subjects receiving the Impella ECP
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Impella ECP · No Placebo Group · N/A

Subjects receiving the Impella ECP
Device
Experimental Group · 1 Intervention: Impella ECP · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through end of study, 30 days

Who is running the clinical trial?

Abiomed Inc.Lead Sponsor
35 Previous Clinical Trials
33,400 Total Patients Enrolled
1 Trials studying High Risk Percutaneous Coronary Interventions
224 Patients Enrolled for High Risk Percutaneous Coronary Interventions
Seth Bilazarian, MDStudy DirectorAbiomed Inc.
1 Previous Clinical Trials
256 Total Patients Enrolled
Shon Chakrabarti, MDStudy DirectorAbiomed Inc.
Duane Pinto, MDPrincipal InvestigatorBeth Israel Deaconess Medical Center
1 Previous Clinical Trials
256 Total Patients Enrolled
Chuck Simonton, MDStudy DirectorAbiomed Inc.
1 Previous Clinical Trials
256 Total Patients Enrolled

Eligibility Criteria

Age 18 - 90 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are scheduled for an elective or urgent high risk percutaneous coronary intervention with hemodynamic support.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top